Earnings Ahead

VRTX - Vertex Pharmaceuticals Incorporated

385.76 9.56 2.54

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

About

Profile

Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes pharmaceutical products. The Company develops drugs for the treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease, and neurological disorders. Vertex Pharma


Headquarters

Boston, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

VRTX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Vertex shares dip 2% as Q3 revenue, guidance falls shy of Street estimates
  • Vertex Pharmaceuticals Non-GAAP EPS of $4.08 beats by $0.11, revenue of $2.48B misses by $20M
  • Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
  • Biotechs rally with gene editing stocks among notable gainers
  • Vertex Pharmaceuticals Q3 2023 Earnings Preview
  • Goldman Sachs' 25 'conviction list' stocks to buy
  • Biggest stock movers today: AMD, WeWork, Paycom Software, CRISPR Therapeutics and more
  • CRISPR gains after FDA AdCom on gene editing therapy
  • CRISPR, Vertex gene editing therapy gets warm response from FDA panel
  • Gene editing stocks gain after Eli Lilly deal amid FDA AdCom
  • CRISPR on hold for trading amid key FDA meeting on gene editing drug
  • Pharma, PBMs spar over rising drug costs amid public scrutiny
  • FDA reviewers recommend more studies for Vertex sickle cell therapy: report
  • Editas upgraded at Citi ahead of FDA AdCom on gene editing therapy
  • Vertex Pharmaceuticals marketing chief disposes $2M worth stock
  • Vertex Pharmaceuticals executive chairman disposes stake worth $4.85M
  • Vertex updated data on diabetes candidate VX-880 encouraging
  • Vertex appoints Atkinson EVP Chief Technical Operations Officer
  • Bluebird bio favored at Baird as sickle cell disease space gets busy
  • Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
January 26, 2022 3.37 / 3.29 2.07B / 2B Beat!
November 2, 2021 3.56 / 3.09 1.98B / 1.86B Beat!
July 29, 2021 3.11 / 2.53 1.79B / 1.72B Beat!
April 29, 2021 2.98 / 2.7 1.72B / 1.66B Beat!
February 1, 2021 2.51 / 2.57 1.63B / 1.59B Beat!
October 29, 2020 2.64 / 2.35 1.54B / 1.49B Beat!
July 30, 2020 2.61 / 2.09 1.52B / 1.39B Beat!
April 29, 2020 2.56 / 1.87 1.52B / 1.3B Beat!
January 30, 2020 1.7 / 1.21 1.26B / 1.01B Beat!
October 30, 2019 1.23 / 1.15 949.83M / 950.95M
July 31, 2019 1.26 / 1.07 941.28M / 886.16M Beat!
April 30, 2019 1.14 / 1.01 858.29M / 851.35M Beat!
February 5, 2019 1.3 / 1.06 869.44M / 820.13M Beat!
October 24, 2018 1.09 / 1.02 783.86M / 790.69M
July 25, 2018 0.94 / 0.75 751.22M / 680.64M Beat!
April 26, 2018 0.76 / 0.63 638.88M / 622.11M Beat!
January 31, 2018 0.61 / 0.53 651.6M / 595.92M Beat!
October 25, 2017 0.53 / 0.31 578.2M / 520.1M Beat!
July 26, 2017 0.39 / 0.35 1.26B / 487.5M Beat!
April 27, 2017 0.41 / 0.37 714.7M / - Beat!
Date Price Open High Low Vol Change
May 17 445.21 442
446.09
440.35
1.4M 1.04%
May 16 440.64 434.59
441.66
432.31
1.2M 0.72%
May 15 437.49 434.59
439.15
429.15
1.1M 2.08%
May 14 428.59 429.07
429.93
422.44
936K -0.31%
May 13 429.93 425.99
430.49
424.85
940K 1.69%
 
May 10 422.78 420.67
423.32
417.51
1.1M 0.90%
May 9 418.99 419
421.05
416.03
676K 0.04%
May 8 418.82 413.33
425.65
412.12
1.7M 2.09%
May 7 410.24 406.42
415.67
394.73
1.4M 1.92%
May 6 402.5 402.3
406.77
401.2
1.2M 0.38%
May 3 400.97 401.5
405.59
397.59
849K 0.20%
May 2 400.16 402.95
404.01
398.46
1.0M -0.6%
May 1 402.58 392.81
406.9
392.47
963K 2.47%
Apr 30 392.87 396.2
396.69
391.76
1.1M -0.84%
Apr 29 396.2 397.48
399.31
394.35
605K -0.32%
Apr 26 397.48 393.52
399.68
393.49
682K -0.06%
Apr 25 397.7 402.44
403.88
393
788K -0.76%
Apr 24 400.76 404.5
406.83
399.29
806K -1.02%
Apr 23 404.91 404
406.86
403.47
1.1M 1.25%
Apr 22 399.92 397.3
406.34
396
1.3M 1.43%
Apr 19 394.28 394.72
396.98
391.25
1.3M 0.20%
Apr 18 393.48 394.19
396.14
391.01
949K 0.10%
Apr 17 393.1 394.94
398.11
392.03
881K -0.27%
Apr 16 394.17 396.88
398.49
392.81
695K -0.8%
Apr 15 397.36 400
402.49
396.69
1.3M 0.20%
Apr 12 396.55 396.57
400.14
393.76
1.2M -0.92%
Apr 11 400.23 404.3
404.69
398.85
1.1M 0.67%
Apr 10 397.58 399.89
401
394.81
1.0M -1.71%
Apr 9 404.48 406
406.45
399.3
727K 0.06%
Apr 8 404.22 403.45
404.6
399
746K -0.6%
Apr 5 406.67 404.29
409.93
400.83
696K 0.66%
Apr 4 404.01 412.64
412.64
403.15
957K -1.17%
Apr 3 408.81 409.45
414.95
408.25
729K -0.15%
Apr 2 409.42 419
420.87
406.73
975K -2.63%
Apr 1 420.48 420.43
421.45
414.74
735K 0.59%
Mar 28 418.01 419.48
420.67
415.06
1.1M 0.17%
Mar 27 417.32 420.3
420.42
412.65
905K -0.27%
Mar 26 418.46 417.38
419.55
414.86
953K 0.58%
Mar 25 416.03 415.66
418.28
414.97
733K 0.09%
Mar 22 415.66 417.75
417.75
412.19
822K -0.01%
Mar 21 415.71 415.61
419.26
414
895K 0.87%
Mar 20 412.11 414.33
414.51
409.02
793K -0.74%
Mar 19 415.2 412.51
415.7
411.1
845K 0.93%
Mar 18 411.38 410.49
415.5
409.24
926K 0.91%
Mar 15 407.69 410.1
411.64
406.97
1.9M -0.26%
Mar 14 408.77 414.01
414.98
407.08
1.0M -1.07%
Mar 13 413.2 414.46
415.92
410.39
764K 0.18%
Mar 12 412.45 413
416.11
409.02
867K -0.49%
Mar 11 414.47 414
416.7
409.52
1.3M 0.21%
Mar 8 413.59 412.34
416.25
410.95
815K 0.74%
Mar 7 410.54 415.14
418.32
410.23
923K -0.32%
Mar 6 411.85 414.23
418.22
410.46
1.2M -0.86%
Mar 5 415.44 424.87
425.49
414.04
1.1M -2.03%
Mar 4 424.03 432.73
433.99
422.16
1.1M -2.02%
Mar 1 432.76 423.2
433.67
422.95
1.1M 2.86%
Feb 29 420.74 429.18
429.18
420.24
1.8M -1.46%
Feb 28 426.97 429.6
433.49
425.71
783K -0.92%
Feb 27 430.92 434.13
437
430.52
909K -0.59%
Feb 26 433.48 425.7
434.26
425.7
788K 0.78%
Feb 23 430.11 430
434.5
429.07
750K 0%